Labcorp announced today the FDA has granted Emergency Use Authorization, or EUA, for its Mpox PCR Test Home Collection Kit to aid in the diagnosis of infection with non-variola Orthopoxvirus, including the monkeypox virus that causes monkeypox, also known as mpox. The test is the first mpox at-home collection kit authorized by FDA and is available to physicians to order for patients 18 years of age or older who are suspected of mpox infection.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp announces launch of Labcorp Plasma Detect
- Labcorp ,Xcell Biosciences deepen tie-up, adding new elements to collaboration
- Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business
- Labcorp to acquire select assets of BioReference Health for $237.5M
- Labcorp Announces Q1 2024 Earnings Call and Webcast